| Literature DB >> 34431029 |
Yat Kwan Wong1, Jun Mei Wu1,2, Guodong Zhou3, Frank Zhu4, Quan Zhang5, Xin Jing Yang1, Zongshi Qin1, Ni Zhao3, Haiyong Chen6, Zhang-Jin Zhang7.
Abstract
Depression is a common psychiatric illness affecting over 300 million people globally. Acupuncture has been reported to be a safe complementary treatment for depression. This study is aimed to investigate the efficacy and mechanism of combining acupuncture with antidepressants in treating depression compared to the sole use of antidepressants. Seventy depression patients were randomly assigned to the treatment group (n = 50) and control group (n = 20). The treatment group received acupuncture combined antidepressants treatment for 3 weeks, while the control group took antidepressants monotherapy for 3 weeks. Among the 70 patients, 40 participants (20 control; 20 treatment) were randomized for studying functional connectivity (FC) of the dorsolateral prefrontal cortex (DLPFC) measured by the functional near-infrared spectroscopy. The primary outcome was HAMD-17 and secondary outcomes were PHQ-9, and the relationships of resting-state FC (rsFC) with the depression severity. PHQ-9 and HAMD-17 scores in the treatment group were significantly lower than those in the control group at Week 3 (p = 0.01) with effect sizes of -0.4 and -0.61 respectively. The rsFC in F1, F3, AF3, AF7, FC3, FC5 (left DLPFC, 10-20 system), AF8, and F6 (right DLPFC) in the treatment group had significant temporal correlation (p < 0.05, FDR corrected) in DLPFC compared to the channels in the control group. No significant correlation was found between the changes of rsFC and depression severity. In conclusion, depressed patients receiving acupuncture combined with antidepressants have improvement of depressive symptoms and the stronger rsFC in the DLPFC compared to those using antidepressants alone.Entities:
Keywords: Acupuncture; Antidepressant; Clinical trial; Depression; Functional near-infrared spectroscopy
Mesh:
Substances:
Year: 2021 PMID: 34431029 PMCID: PMC8804104 DOI: 10.1007/s13311-021-01098-3
Source DB: PubMed Journal: Neurotherapeutics ISSN: 1878-7479 Impact factor: 6.088